uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted January 28, 2017

FDA Testing Confirms Elevated Levels of Belladonna in Some Homeopathic Teething Products

On January 27, 2017, the FDA announced that its laboratory analysis found "inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label."

The agency contacted the manufacturer of Hyland's homeopathic teething products, regarding a recall of its homeopathic teething tablet products labeled as containing belladonna, however, the company had not agreed to conduct a recall as of the time of the FDA's announcement.

(In November 2016, Raritan Pharmaceuticals, a contract manufacturer for Homeolab USA, issued a recall of three homeopathic products for infants and/or children which contain belladonna extract.)

Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, stated in the FDA's press release, "The body's response to belladonna in children under two years of age is unpredictable and puts them at unnecessary risk. We recommend that parents and caregivers not give these homeopathic teething tablets to children and seek advice from their health care professional for safe alternatives."

The agency also advised consumers seek immediate medical care if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after using homeopathic teething products.

See Related Warnings:

Homeopathic Teething Tablets and Ear Relief Products Containing Belladonna Recalled

Homeopathic Teething Tablets and Gels May Pose Danger, FDA Warns

Don't Rely on Homeopathic Asthma Products, FDA Warns

Weight Loss Supplement Recalled

Homeopathic Products Recalled Due to Allergy Risk

For more about the recall, use the link below.